Citation Impact

Citing Papers

An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Deciphering O -glycoprotease substrate preferences with O-Pair Search
2022 StandoutNobel
Microbiota in health and diseases
2022 Standout
Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury
2017
Microbubbles in ultrasound-triggered drug and gene delivery
2008 Standout
Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms
2022
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
2020
Microbiota, cirrhosis, and the emerging oral-gut-liver axis
2017
Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation
2020
Hallmarks of aging: An expanding universe
2023 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Commensal bacteria make GPCR ligands that mimic human signalling molecules
2017 Nature
Acute-on-chronic liver failure in cirrhosis
2016
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Gut microbiome, liver immunology, and liver diseases
2020
Gut microbiome and health: mechanistic insights
2022 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease
2019
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
2020
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
Acute-on-chronic liver failure: terminology, mechanisms and management
2016
Revealing the human mucinome
2022 StandoutNobel
Hydrodynamic Gene Delivery: Its Principles and Applications
2007
Global burden of liver disease: 2023 update
2023 Standout
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
2019 Standout
The utility of radiological imaging in nonalcoholic fatty liver disease
2002 Standout
Acute-on-chronic Liver Failure
2016
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
2016 Standout
The microbiota in cirrhosis and its role in hepatic decompensation
2021
Quantitative sequencing clarifies the role of disruptor taxa, oral microbiota, and strict anaerobes in the human small-intestine microbiome
2021
Gut microbiota in human metabolic health and disease
2020 Standout
The gut–liver axis and the intersection with the microbiome
2018
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Glycoproteomics
2022 StandoutNobel
Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice
2020
Clinical Oncology Society of Australia position statement on exercise in cancer care
2018
Overview of pharmacological activities ofAndrographis paniculataand its major compound andrographolide
2018 Standout
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Electron-Based Dissociation Is Needed for O-Glycopeptides Derived from OpeRATOR Proteolysis
2020 StandoutNobel
Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists
2021
The role of the gut microbiome in chronic liver disease: the clinical evidence revised
2019
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
2018
Gut Microbiota’s Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics
2018
The Human Microbiota in Health and Disease
2017
Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.)
2019 Standout
Nonalcoholic Fatty Liver Disease
2019
Gut Microbiota and Host Reaction in Liver Diseases
2015
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease
2020 Standout

Works of Ding Shi being referenced

Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis
2014
Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats
2017
Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology
2016
Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
2019
Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration
2004
Protective Effect of Akkermansia muciniphila against Immune-Mediated Liver Injury in a Mouse Model
2017
Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota
2017
Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis
2018
Pre- and post-diagnosis physical activity is associated with survival benefits of colorectal cancer patients: a systematic review and meta-analysis
2016
Characterization of the circulating microbiome in acute‐on‐chronic liver failure associated with hepatitis B
2019
Gut dysbiosis in acute‐on‐chronic liver failure and its predictive value for mortality
2015
Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis
2016
Clinical application of angiotensin receptor blockers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis
2018
Rankless by CCL
2026